Benzinga's Top Upgrades, Downgrades For May 13, 2020

Upgrades

• Oppenheimer changed the rating for Inter Parfums Inc IPAR from Underperform to Neutral. In the first quarter, Inter Parfums showed an EPS of $0.32, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $81.40 and a 52-week-low of $34.20. Inter Parfums's stock last closed at $41.67 per share.
• For Charles River Laboratories International Inc CRL, UBS upgraded the stock from Neutral to Buy. Charles River earned $1.84 in the first quarter, compared to $1.40 in the year-ago quarter. The stock has a 52-week-high of $179.38 and a 52-week-low of $95.58. Charles River's stock last closed at $161.19 per share.
• UBS upgraded the stock for Covanta Holding Corp CVA from Neutral to Buy. For the first quarter, Covanta Holding had an EPS of ($0.10), compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $18.38 and a 52-week-low of $6.57. Covanta Holding's stock last closed at $8.38 per share.
• For Inter Parfums Inc IPAR, DA Davidson upgraded the stock from Underperform to Neutral. Inter Parfums earned $0.32 in the first quarter, compared to $0.60 in the year-ago quarter. The stock has a 52-week-high of $81.40 and a 52-week-low of $34.20. Inter Parfums's stock last closed at $41.67 per share.
• For CymaBay Therapeutics Inc CBAY, B. Riley FBR upgraded the stock from Neutral to Buy. In the first quarter, CymaBay Therapeutics showed an EPS of ($0.19), compared to ($0.37) from the year-ago quarter. The stock has a 52-week-high of $13.32 and a 52-week-low of $1.21. CymaBay Therapeutics's stock last closed at $4.18 per share.
• Wells Fargo upgraded the stock for United Natural Foods Inc UNFI from Underweight to Equal-Weight. United Natural Foods earned $0.32 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $16.70 and a 52-week-low of $5.00. United Natural Foods's stock last closed at $15.60 per share.

Downgrades

• Compass Point changed the rating for TriplePoint Venture Growth BDC Corp TPVG from Buy to Neutral. In the first quarter, TriplePoint Venture Gwth showed an EPS of $0.41, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $17.17 and a 52-week-low of $2.80. TriplePoint Venture Gwth's stock last closed at $8.39 per share.
• UBS changed the rating for ONEOK Inc OKE from Buy to Neutral. For the first quarter, ONEOK had an EPS of $0.83, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $78.48 and a 52-week-low of $12.16. ONEOK's stock last closed at $33.03 per share.
• For Quaker Chemical Corp KWR, Janney Capital downgraded the stock from Buy to Neutral. Quaker Chemical earned $1.38 in the first quarter, compared to $1.41 in the year-ago quarter. The stock has a 52-week-high of $209.05 and a 52-week-low of $108.14. Quaker Chemical's stock last closed at $166.06 per share.
• Loop Capital changed the rating for Steven Madden Ltd SHOO from Buy to Hold. Steven Madden earned $0.39 in the fourth quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $44.80 and a 52-week-low of $16.38. Steven Madden's stock last closed at $21.65 per share.
• Morgan Stanley downgraded the stock for Xcel Energy Inc XEL from Equal-Weight to Underweight. For the first quarter, Xcel Energy had an EPS of $0.56, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $72.14 and a 52-week-low of $46.58. Xcel Energy's stock last closed at $58.79 per share.
• Credit Suisse changed the rating for Valaris PLC VAL from Neutral to Underperform. Valaris earned ($1.66) in the first quarter. The stock has a 52-week-high of $8.75 and a 52-week-low of $0.30. Valaris's stock last closed at $0.37 per share.
• Raymond James downgraded the stock for Spirit Airlines Inc SAVE from Outperform to Market Perform. For the first quarter, Spirit Airlines had an EPS of ($0.86), compared to year-ago quarter EPS of $0.84. The stock has a 52-week-high of $55.21 and a 52-week-low of $7.01. Spirit Airlines's stock last closed at $9.44 per share.
• Morgan Stanley downgraded the stock for Radius Health Inc RDUS from Overweight to Equal-Weight. In the first quarter, Radius Health showed an EPS of ($0.59), compared to ($0.70) from the year-ago quarter. The stock has a 52-week-high of $29.97 and a 52-week-low of $10.32. Radius Health's stock last closed at $13.84 per share.

Initiations

• With a rating of Outperform, Cowen & Co. initiated coverage on Theravance Biopharma Inc TBPH. The price target is set at $42.00 for Theravance Biopharma. Theravance Biopharma earned ($1.14) in the first quarter, compared to ($1.32) in the year-ago quarter. The stock has a 52-week-high of $31.54 and a 52-week-low of $15.18. Theravance Biopharma's stock last closed at $28.49 per share.
• With a rating of Buy, HC Wainwright & Co. initiated coverage on Fate Therapeutics Inc FATE. The price target is set at $42.00 for Fate Therapeutics. Fate Therapeutics earned ($0.44) in the first quarter, compared to ($0.30) in the year-ago quarter. The stock has a 52-week-high of $32.39 and a 52-week-low of $12.59. Fate Therapeutics's stock last closed at $28.75 per share.